Manulife reports strong 2021 results with record net income of $7.1 billion and core earnings of $6.5 billion, with double-digit growth in APE sales and new business value; Global Wealth and Asset Management net inflows tripled to $27.9 billion
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945
This earnings news release for |
- Net income attributed to shareholders of
$7.1 billion in 2021, up$1.2 billion from 2020, and$2.1 billion in 4Q21, up$304 million from the fourth quarter of 2020 ("4Q20") - Core earnings1 of
$6.5 billion in 2021, up 26% on a constant exchange rate basis from 2020, and$1.7 billion in 4Q21, up 20% on a constant exchange rate basis from 4Q202 - Strong LICAT ratio3 of 142%
- Core ROE4 of 13.0% in 2021 and 12.7% in 4Q21, and ROE of 14.2% in 2021 and 15.6% in 4Q21
- NBV5 of
$2.2 billion in 2021, up 31%6 from 2020, and$555 million in 4Q21, up 17% from 4Q20 - APE sales5 of
$6.1 billion in 2021, up 13% from 2020, and$1.4 billion in 4Q21, up 5% from 4Q20 - Global Wealth and Asset Management ("Global WAM") net inflows5 of
$27.9 billion in 2021 compared with net inflows of$8.9 billion in 2020 and net inflows of$8.1 billion in 4Q21 compared with net inflows of$2.8 billion in 4Q20. A record year for our retail wealth business with net inflows of$29.2 billion - Global WAM average AUMA5 increased by 20% in 2021
- Remittances5 were
$4.4 billion in 2021 compared with$1.6 billion in 2020, an increase of$2.8 billion - Quarterly common share dividend increased by 18% in 4Q21
- Launched a Normal Course Issuer Bid ("NCIB") that permits repurchase of up to 5% of outstanding common shares
"Our ability to adapt and serve clients across the globe who are navigating a very uncertain environment continues to drive our operating results with record net income of
"I am incredibly proud of the way our colleagues around the world have continued to make decisions easier and lives better for our customers. We are delivering on our strategic priorities, enhancing our organizational culture and ESG capabilities, and achieving top quartile employee engagement scores,"
"We are pleased to have delivered strong financial performance in 2021 including Core ROE of 13% and ROE of 14.2%," said
"We take pride in our products and services, such as insurance protection, well-being offerings, and retirement and wealth management solutions, which positions us well to continue helping our customers live better, happier and healthier lives," said
_______________________________ |
|
1 |
Core earnings is a non-GAAP financial measure. For more information on non-GAAP and other financial measures, see "Non-GAAP and Other Financial Measures" below and that section in our 2021 Management's Discussion and Analysis ("2021 MD&A"), which is incorporated by reference. |
2 |
Percentage growth / declines in core earnings stated on a constant exchange rate basis is a non-GAAP ratio. |
3 |
Life Insurance Capital Adequacy Test ("LICAT") ratio of The |
4 |
Core return on common shareholders' equity ("Core ROE") is a non-GAAP ratio. |
5 |
For more information on new business value ("NBV"), annualized premium equivalent ("APE") sales, net flows, average assets under management and administration ("average AUMA") and remittances, see "Non-GAAP and Other Financial Measures" below. |
6 |
In this news release, percentage growth / declines in NBV, APE sales, gross flows and average AUMA are stated on a constant exchange rate basis. |
2021 BUSINESS HIGHLIGHTS:
In
- We completed the acquisition of Aviva Vietnam, along with the beginning of a 16-year bancassurance partnership with VietinBank that enables a full suite of insurance, wealth and retirement solutions to be made available to VietinBank customers.
- We increased the number of contracted agents to over 117,000 and our number of
Million Dollar Round Table agents grew by 64% compared with 2020. - We continued to expand the reach of our agency force in
China with the opening of our newest branch inShaanxi province. We now operate in 52 cities across 15 provinces, providing access to over 60% ofChina 's population and which represents over 70% of GDP.
In
- We introduced Personalized Medicine, which provides access to advanced pharmacogenetics to help group benefit members and their health team find the most effective medication for their condition.
- We expanded our Manulife Vitality program to reward customers who received their COVID-19 vaccine.
- We launched the Manulife Vitality HealthyMind reward program to help our individual insurance customers improve their mental and emotional wellbeing.
In the
- We entered into an agreement to reinsure over 75% of the legacy variable annuity block, consisting primarily of policies with guaranteed minimum withdrawal benefits riders. The transaction, which closed on
February 1, 2022 , is estimated to release approximately$2.0 billion of additional capital reflecting approximately$1.3 billion of net LICAT required capital, and a one-time after-tax gain of approximately$750 million to net income attributed to shareholders.1
______________________________ |
1 See "Caution regarding forward-looking statements" below. Projected capital release and gain based on |
- We experienced sales momentum with sales ahead of the prior year in almost every major category and reported record sales in our international business. We achieved record full year sales of
US$295 million , an increase of 34% compared with 2020, from products with the John Hancock Vitality PLUS feature. We believe our John Hancock Vitality feature is proving to be the right solution for these times as there is a heightened awareness around wellbeing highlighted by COVID-19. - We also launched a preferred partnership with Allstate, which provides insurance to approximately 15 million customers, to be one of three carrier partners for its more than 11,000 agents and 1,000 life specialists. In time we expect this relationship, enabled by our digital submission capabilities, will drive significant life insurance sales.1
In Global WAM, we continued to diversify our offerings.
- We expanded our sustainable investing products with the launch of investment strategies in Sustainable Asia Bond, Global Climate, and ESG Asian Multi-Asset Income. Additionally,
Manulife Investment Management was accepted as a signatory to theUK Stewardship Code, which is recognized globally as a best practice benchmark in investment stewardship. Nearly 200 asset managers, pension funds and others applied but only 123 were accepted after a rigorous review by theFinancial Reporting Council 2. - We also secured an Alternative Investment Fund Managers ("AIFM") license to offer
European Union ("EU") private market funds in our key European markets, positioning us to drive the expansion and offering of our private market investment capabilities within the EU. - We expanded our retail product line-up beyond traditional mutual funds with new actively managed Exchange Traded Funds in both
Canada and theU.S. and we furthered Separately Managed Accounts offerings in theU.S. , with each category generating over$1 billion in net inflows in 2021.
Additionally, we continued to enhance our digital capabilities and rolled out numerous initiatives to advance our strategy to become a digital, customer leader.
- In
Asia , ePOS, our digital onboarding app, is enabling our agents with faster, error-free submissions with 82% of applications digitally submitted, representing a 22% year over year increase. 79% of submitted cases are auto-underwritten. - In the
U.S. , we completed the iPipeline integration with the JH brokerage eApp. This integration provides 66% of our regular distribution partners with access to next-generation sales tools and decreases the overall cycle time for applications submitted via this preferred channel by 49% year over year. It also enabled access to over 250 firms, including a new partnership with Allstate and its more than 11,000 agents. - Aided by the above initiatives, overall new business applications submitted digitally increased by 15 percentage points in 2021 to 71%.
- In
Canada , we became the first Canadian company to use artificial intelligence ("AI") in underwriting mortgage creditor insurance in our individual insurance business. Since its introduction, one-third of our applications have been approved using AI, resulting in auto adjudication of more than$1 billion of face amount in 2021. - In Global WAM, Asia Retail's online investment platform, Manulife iFUNDS continued to show strong momentum in 2021 compared with 2020, with a 39% increase in gross flows3, a 29% increase in new accounts opened, and a 198% increase in monthly investment plans.
- In
U.S. Retirement , 88% of plan enrollees adopted our new digital express enrollment capability, that delivers a simple, fast and seamless way to enroll in their plan and benefit from access to personalized guidance. This resulted in an 11% increase in participation and six times the managed accounts conversion rate when compared to the previous enrollment process.
__________________________ |
|
1 |
See "Caution regarding forward-looking statements below. |
2 |
The |
3 |
For more information on gross flows, see "Performance and Non-GAAP Measures" below and in our 2021 MD&A. |
FINANCIAL HIGHLIGHTS:
Quarterly Results |
Full Year Results |
|||||||
($ millions, unless otherwise stated) |
4Q21 |
4Q20 |
2021 |
2020 |
||||
Profitability: |
||||||||
Net income attributed to shareholders |
$ |
2,084 |
$ |
1,780 |
$ |
7,105 |
$ |
5,871 |
Core earnings |
$ |
1,708 |
$ |
1,474 |
$ |
6,536 |
$ |
5,516 |
Diluted earnings per common share ($) |
$ |
1.03 |
$ |
0.89 |
$ |
3.54 |
$ |
2.93 |
Diluted core earnings per common share ("Core EPS") ($)(1) |
$ |
0.84 |
$ |
0.74 |
$ |
3.25 |
$ |
2.75 |
Return on common shareholders' equity ("ROE") |
15.6% |
14.1% |
14.2% |
11.6% |
||||
Core ROE |
12.7% |
11.6% |
13.0% |
10.9% |
||||
Expense efficiency ratio(1) |
49.0% |
52.7% |
48.9% |
52.9% |
||||
General expenses |
$ |
2,000 |
$ |
1,968 |
$ |
7,828 |
$ |
7,510 |
Business Performance: |
||||||||
Asia new business value |
$ |
391 |
$ |
368 |
$ |
1,666 |
$ |
1,387 |
Canada new business value |
$ |
82 |
$ |
65 |
$ |
307 |
$ |
255 |
|
$ |
82 |
$ |
56 |
$ |
270 |
$ |
160 |
Total new business value |
$ |
555 |
$ |
489 |
$ |
2,243 |
$ |
1,802 |
Asia APE sales |
$ |
890 |
$ |
996 |
$ |
4,050 |
$ |
3,869 |
Canada APE sales |
$ |
295 |
$ |
245 |
$ |
1,227 |
$ |
1,148 |
|
$ |
244 |
$ |
178 |
$ |
788 |
$ |
609 |
Total APE sales |
$ |
1,429 |
$ |
1,419 |
$ |
6,065 |
$ |
5,626 |
Global WAM net flows ($ billions) |
$ |
8.1 |
$ |
2.8 |
$ |
27.9 |
$ |
8.9 |
Global WAM gross flows ($ billions) |
$ |
36.0 |
$ |
31.5 |
$ |
144.7 |
$ |
130.2 |
Global WAM assets under management and administration ($ billions)(2) |
$ |
855.9 |
$ |
753.6 |
$ |
855.9 |
$ |
753.6 |
Global WAM total invested assets ($ billions) |
$ |
4.5 |
$ |
4.8 |
$ |
4.5 |
$ |
4.8 |
Global WAM net segregated funds net assets ($ billions) |
$ |
252.6 |
$ |
229.8 |
$ |
252.6 |
$ |
229.8 |
Financial Strength: |
||||||||
MLI's LICAT ratio |
142% |
149% |
142% |
149% |
||||
Financial leverage ratio |
25.8% |
26.6% |
25.8% |
26.6% |
||||
Book value per common share ($) |
$ |
26.78 |
$ |
25.00 |
$ |
26.78 |
$ |
25.00 |
Book value per common share excluding AOCI ($) |
$ |
24.12 |
$ |
21.74 |
$ |
24.12 |
$ |
21.74 |
(1) This item is a non-GAAP ratio. |
(2) This item is a non-GAAP financial measure. |
PROFITABILITY:
Reported net income attributed to shareholders of
The
The
Delivered core earnings of
The increase in core earnings in 2021 compared with 2020 was driven by the recognition of core investment gains1 in 2021 (compared with nil core investment gains in 2020), higher new business gains in all segments, higher net fee income from higher average AUMA in Global WAM, which benefitted from the favourable impact of markets and net inflows, higher investment income in Corporate and Other which benefitted from higher net gains from available-for-sale equities and seed money investments in 2021, and in-force business growth in all segments. These items were partially offset by unfavourable policyholder experience and a charge in our Property and Casualty Reinsurance business for losses related to Hurricane Ida and the European floods.
The increase in core earnings in 4Q21 compared with 4Q20 was driven by the recognition of core investment gains in 2021 (compared with nil core investment gains in the prior year quarter), higher net fee income from higher average AUMA in Global WAM, which benefitted from the favourable impact of markets and net inflows, higher new business gains in the
BUSINESS PERFORMANCE:
New business value ("NBV") of
NBV was
NBV was
__________________ |
|
1 |
Core investment gains are disclosed under the OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
2 |
Other Emerging Markets includes |
3 |
Asia Other excludes |
Annualized premium equivalent ("APE") sales of
APE sales were
APE sales were
Reported Global Wealth and Asset Management net inflows of
Net inflows were
Net inflows were
QUARTERLY EARNINGS RESULTS CONFERENCE CALL
The conference call will also be webcast through Manulife's website at
The Fourth Quarter 2021 Statistical Information Package is also available on the Manulife website at: www.manulife.com/en/investors/results-and-reports.
EARNINGS:
The following table presents net income attributed to shareholders, consisting of core earnings and details of the items excluded from core earnings:
Quarterly Results |
Full Year Results |
|||||||||
($ millions) |
4Q21 |
3Q21 |
4Q20 |
2021 |
2020 |
|||||
Core earnings |
||||||||||
|
$ |
547 |
$ |
533 |
$ |
571 |
$ |
2,176 |
$ |
2,110 |
|
286 |
311 |
316 |
1,179 |
1,174 |
|||||
|
467 |
490 |
479 |
1,936 |
1,995 |
|||||
Global Wealth and Asset Management |
387 |
351 |
304 |
1,406 |
1,100 |
|||||
Corporate and Other (excluding core investment gains) |
(79) |
(268) |
(196) |
(561) |
(863) |
|||||
Core investment gains(1) |
100 |
100 |
- |
400 |
- |
|||||
Total core earnings |
$ |
1,708 |
$ |
1,517 |
$ |
1,474 |
$ |
6,536 |
$ |
5,516 |
Items excluded from core earnings:(1) Investment-related experience outside of core earnings |
126 |
700 |
585 |
1,642 |
(792) |
|||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities |
398 |
(597) |
(323) |
(817) |
932 |
|||||
Change in actuarial methods and assumptions |
- |
(41) |
- |
(41) |
(198) |
|||||
Restructuring charge |
- |
- |
- |
(115) |
- |
|||||
Reinsurance transaction, tax-related items and other |
(148) |
13 |
44 |
(100) |
413 |
|||||
Net income attributed to shareholders |
$ |
2,084 |
$ |
1,592 |
$ |
1,780 |
$ |
7,105 |
$ |
5,871 |
(1) These items are disclosed under OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
NON-GAAP AND OTHER FINANCIAL MEASURES:
The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards ("IFRS") as issued by the
Non-GAAP financial measures include core earnings (loss); pre-tax core earnings; core earnings available to common shareholders; core general expenses; and assets under management and administration ("AUMA").
Non-GAAP ratios include core return on common shareholders' equity ("core ROE"); diluted core earnings per common share ("core EPS"); expense efficiency ratio; and percentage growth/decline on a constant exchange rate basis in any of the above non-GAAP financial measures.
Other specified financial measures include assets under administration; embedded value; NBV; APE sales; gross flows; net flows; average assets under management and administration ("average AUMA"); remittances and percentage growth/decline in such other financial measures.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the section "Non-GAAP and Other Financial Measures" in our 2021 MD&A, which is incorporated by reference.
Reconciliation of core earnings to net income attributed to shareholders
2021 |
||||||||||||
($millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate and Other |
|
||||||
Income (loss) before income taxes |
$ |
3,188 |
$ |
1,791 |
$ |
2,484 |
$ |
1,641 |
$ |
(979) |
$ |
8,125 |
Income tax (expense) recovery |
||||||||||||
Core earnings |
(322) |
(413) |
(418) |
(234) |
27 |
(1,360) |
||||||
Items excluded from core earnings |
(120) |
77 |
32 |
(1) |
159 |
147 |
||||||
Income tax (expense) recovery |
(442) |
(336) |
(386) |
(235) |
186 |
(1,213) |
||||||
Net income (post-tax) |
2,746 |
1,455 |
2,098 |
1,406 |
(793) |
6,912 |
||||||
Less: Net income (post-tax) attributed to |
||||||||||||
Non-controlling interests |
256 |
- |
- |
- |
(1) |
255 |
||||||
Participating policyholders |
(567) |
101 |
18 |
- |
- |
(448) |
||||||
Net income (loss) attributed to shareholders (post-tax) |
3,057 |
1,354 |
2,080 |
1,406 |
(792) |
7,105 |
||||||
Less: Items excluded from core earnings(1) |
||||||||||||
Investment-related experience outside of core earnings |
313 |
329 |
1,341 |
- |
(341) |
1,642 |
||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities |
169 |
(89) |
(727) |
- |
(170) |
(817) |
||||||
Change in actuarial methods and assumptions |
343 |
(65) |
(314) |
- |
(5) |
(41) |
||||||
Restructuring charge |
- |
- |
- |
- |
(115) |
(115) |
||||||
Reinsurance transactions, tax related items and other |
56 |
- |
(156) |
- |
- |
(100) |
||||||
Core earnings (post-tax) |
$ |
2,176 |
$ |
1,179 |
$ |
1,936 |
$ |
1,406 |
$ |
(161) |
$ |
6,536 |
Income tax on core earnings (see above) |
322 |
413 |
418 |
234 |
(27) |
1,360 |
||||||
Core earnings (pre-tax) |
$ |
2,498 |
$ |
1,592 |
$ |
2,354 |
$ |
1,640 |
$ |
(188) |
$ |
7,896 |
(1) These items are disclosed under OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
Core earnings, CER basis
2021 |
||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global |
Corporate |
Total |
||||||
Core earnings (post-tax) |
$ |
2,176 |
$ |
1,179 |
$ |
1,936 |
$ |
1,406 |
$ |
(161) |
$ |
6,536 |
CER adjustment(1) |
(1) |
- |
9 |
4 |
1 |
13 |
||||||
Core earnings, CER basis (post-tax) |
$ |
2,175 |
$ |
1,179 |
$ |
1,945 |
$ |
1,410 |
$ |
(160) |
$ |
6,549 |
Income tax on core earnings, CER basis(2) |
321 |
413 |
421 |
234 |
(26) |
1,363 |
||||||
Core earnings, CER basis (pre-tax) |
$ |
2,496 |
$ |
1,592 |
$ |
2,366 |
$ |
1, 644 |
$ |
(186) |
$ |
7,912 |
(1) The impact of updating foreign exchange rates to that which was used in 4Q21. |
(2) Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 4Q21. |
Reconciliation of core earnings to net income attributed to shareholders
2020 |
||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate |
|
||||||
Income (loss) before income taxes |
$ |
1,635 |
$ |
390 |
$ |
1,564 |
$ |
1,272 |
$ |
1,910 |
$ |
6,771 |
Income tax (expense) recovery |
||||||||||||
Core earnings |
(336) |
(378) |
(481) |
(172) |
199 |
(1,168) |
||||||
Items excluded from core earnings |
104 |
247 |
186 |
- |
(564) |
(27) |
||||||
Income tax (expense) recovery |
(232) |
(131) |
(295) |
(172) |
(365) |
(1,195) |
||||||
Net income (post-tax) |
1,403 |
259 |
1,269 |
1,100 |
1,545 |
5,576 |
||||||
Less: Net income (post-tax) attributed to |
||||||||||||
Non-controlling interests |
250 |
- |
- |
- |
- |
250 |
||||||
Participating policyholders |
(609) |
64 |
- |
- |
- |
(545) |
||||||
Net income (loss) attributed to shareholders (post-tax) |
1,762 |
195 |
1,269 |
1,100 |
1,545 |
5,871 |
||||||
Less: Items excluded from core earnings(1) |
||||||||||||
Investment-related experience outside of core earnings |
218 |
(260) |
(717) |
- |
(33) |
(792) |
||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities |
(583) |
(817) |
30 |
- |
2,302 |
932 |
||||||
Change in actuarial methods and assumptions |
(41) |
77 |
(301) |
- |
67 |
(198) |
||||||
Restructuring charge |
- |
- |
- |
- |
- |
- |
||||||
Reinsurance transactions, tax related items and other |
58 |
21 |
262 |
- |
72 |
413 |
||||||
Core earnings (post-tax) |
$ |
2,110 |
$ |
1,174 |
$ |
1,995 |
$ |
1,100 |
$ |
(863) |
$ |
5,516 |
Income tax on core earnings (see above) |
336 |
378 |
481 |
172 |
(199) |
1,168 |
||||||
Core earnings (pre-tax) |
$ |
2,446 |
$ |
1,552 |
$ |
2,476 |
$ |
1,272 |
$ |
(1,062) |
$ |
6,684 |
(1) These items are disclosed under OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
Core earnings, CER basis
2020 |
||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global |
Corporate |
Total |
||||||
Core earnings (post-tax) |
$ |
2,110 |
$ |
1,174 |
$ |
1,995 |
$ |
1,100 |
$ |
(863) |
$ |
5,516 |
CER adjustment(1) |
(128) |
- |
(124) |
(42) |
(9) |
(303) |
||||||
Core earnings, CER basis (post-tax) |
$ |
1,982 |
$ |
1,174 |
$ |
1,871 |
$ |
1,058 |
$ |
(872) |
$ |
5,213 |
Income tax on core earnings, CER basis(2) |
323 |
378 |
450 |
169 |
(199) |
1,121 |
||||||
Core earnings, CER basis (pre-tax) |
$ |
2,305 |
$ |
1,552 |
$ |
2,321 |
$ |
1,227 |
$ |
(1,071) |
$ |
6,334 |
(1) The impact of updating foreign exchange rates to that which was used in 4Q21. |
(2) Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 4Q21. |
Reconciliation of core earnings to net income attributed to shareholders
4Q21 |
||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate and Other |
|
||||||
Income (loss) before income taxes |
$ |
684 |
$ |
806 |
$ |
614 |
$ |
438 |
$ |
(61) |
$ |
2,481 |
Income tax (expense) recovery |
||||||||||||
Core earnings |
(68) |
(101) |
(117) |
(52) |
(8) |
(346) |
||||||
Items excluded from core earnings |
(13) |
(77) |
(4) |
- |
10 |
(84) |
||||||
Income tax (expense) recovery |
(81) |
(178) |
(121) |
(52) |
2 |
(430) |
||||||
Net income (post-tax) |
603 |
628 |
493 |
386 |
(59) |
2,051 |
||||||
Less: Net income (post-tax) attributed to |
||||||||||||
Non-controlling interests |
34 |
- |
- |
(1) |
(1) |
32 |
||||||
Participating policyholders |
(76) |
12 |
(1) |
- |
- |
(65) |
||||||
Net income (loss) attributed to shareholders (post-tax) |
645 |
616 |
494 |
387 |
(58) |
2,084 |
||||||
Less: Items excluded from core earnings(1) |
||||||||||||
Investment-related experience outside of core earnings |
58 |
90 |
58 |
- |
(80) |
126 |
||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities |
32 |
240 |
125 |
- |
1 |
398 |
||||||
Change in actuarial methods and assumptions |
- |
- |
- |
- |
- |
- |
||||||
Restructuring charge |
- |
- |
- |
- |
- |
- |
||||||
Reinsurance transactions, tax related items and other |
8 |
- |
(156) |
- |
- |
(148) |
||||||
Core earnings (post-tax) |
$ |
547 |
$ |
286 |
$ |
467 |
$ |
387 |
$ |
21 |
$ |
1,708 |
Income tax on core earnings (see above) |
68 |
101 |
117 |
52 |
8 |
346 |
||||||
Core earnings (pre-tax) |
$ |
615 |
$ |
387 |
$ |
584 |
$ |
439 |
$ |
29 |
$ |
2,054 |
(1) These items are disclosed under OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
Core earnings, CER basis
4Q21 |
||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate |
|
||||||
Core earnings (post-tax) |
$ |
547 |
$ |
286 |
$ |
467 |
$ |
387 |
$ |
21 |
$ |
1,708 |
CER adjustment(1) |
- |
- |
- |
- |
- |
- |
||||||
Core earnings, CER basis (post-tax) |
$ |
547 |
$ |
286 |
$ |
466 |
$ |
387 |
$ |
21 |
$ |
1,708 |
Income tax on core earnings, CER basis(2) |
68 |
101 |
117 |
52 |
8 |
346 |
||||||
Core earnings, CER basis (pre-tax) |
$ |
615 |
$ |
387 |
$ |
584 |
$ |
439 |
$ |
29 |
$ |
2,054 |
(1) The impact of updating foreign exchange rates to that which was used in 4Q21. |
(2) Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 4Q21. |
Reconciliation of core earnings to net income attributed to shareholders
3Q21 |
||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate and Other |
|
||||||
Income (loss) before income taxes |
$ |
650 |
$ |
(101) |
$ |
800 |
$ |
418 |
$ |
(287) |
$ |
1,480 |
Income tax (expense) recovery |
||||||||||||
Core earnings |
(52) |
(109) |
(79) |
(66) |
12 |
(294) |
||||||
Items excluded from core earnings |
(31) |
153 |
(16) |
(1) |
23 |
128 |
||||||
Income tax (expense) recovery |
(83) |
44 |
(95) |
(67) |
35 |
(166) |
||||||
Net income (post-tax) |
567 |
(57) |
705 |
351 |
(252) |
1,314 |
||||||
Less: Net income (post-tax) attributed to |
||||||||||||
Non-controlling interests |
48 |
- |
- |
- |
- |
48 |
||||||
Participating policyholders |
(303) |
(31) |
8 |
- |
- |
(326) |
||||||
Net income (loss) attributed to shareholders (post-tax) |
822 |
(26) |
697 |
351 |
(252) |
1,592 |
||||||
Less: Items excluded from core earnings(1) |
||||||||||||
Investment-related experience outside of core earnings |
62 |
97 |
617 |
- |
(76) |
700 |
||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities |
(129) |
(369) |
(96) |
- |
(3) |
(597) |
||||||
Change in actuarial methods and assumptions |
343 |
(65) |
(314) |
- |
(5) |
(41) |
||||||
Restructuring charge |
- |
- |
- |
- |
- |
- |
||||||
Reinsurance transactions, tax related items and other |
13 |
- |
- |
- |
- |
13 |
||||||
Core earnings (post-tax) |
$ |
533 |
$ |
311 |
$ |
490 |
$ |
351 |
$ |
(168) |
$ |
1,517 |
Income tax on core earnings (see above) |
52 |
109 |
79 |
66 |
(12) |
294 |
||||||
Core earnings (pre-tax) |
$ |
585 |
$ |
420 |
$ |
569 |
$ |
417 |
$ |
(180) |
$ |
1,811 |
(1) These items are disclosed under OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
Core earnings, CER basis
3Q21 |
||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate and Other |
|
||||||
Core earnings (post-tax) |
$ |
533 |
$ |
311 |
$ |
490 |
$ |
351 |
$ |
(168) |
$ |
1,517 |
CER adjustment(1) |
(2) |
- |
- |
(1) |
- |
(3) |
||||||
Core earnings, CER basis (post-tax) |
$ |
531 |
$ |
311 |
$ |
490 |
$ |
350 |
$ |
(168) |
$ |
1,514 |
Income tax on core earnings, CER basis(2) |
51 |
109 |
80 |
66 |
(12) |
294 |
||||||
Core earnings, CER basis (pre-tax) |
$ |
582 |
$ |
420 |
$ |
570 |
$ |
416 |
$ |
(180) |
$ |
1,808 |
(1) The impact of updating foreign exchange rates to that which was used in 4Q21. |
(2) Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 4Q21. |
Reconciliation of core earnings to net income attributed to shareholders
4Q20 |
||||||||||||
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate and Other |
|
||||||
Income (loss) before income taxes |
$ |
755 |
$ |
707 |
$ |
108 |
$ |
361 |
$ |
134 |
$ |
2,065 |
Income tax (expense) recovery |
||||||||||||
Core earnings |
(89) |
(86) |
(110) |
(57) |
49 |
(293) |
||||||
Items excluded from core earnings |
1 |
40 |
108 |
- |
(80) |
69 |
||||||
Income tax (expense) recovery |
(88) |
(46) |
(2) |
(57) |
(31) |
(224) |
||||||
Net income (post-tax) |
667 |
661 |
106 |
304 |
103 |
1,841 |
||||||
Less: Net income (post-tax) attributed to |
||||||||||||
Non-controlling interests |
57 |
- |
- |
- |
- |
57 |
||||||
Participating policyholders |
(29) |
33 |
- |
- |
- |
4 |
||||||
Net income (loss) attributed to shareholders (post-tax) |
639 |
628 |
106 |
304 |
103 |
1,780 |
||||||
Less: Items excluded from core earnings(1) |
||||||||||||
Investment-related experience outside of core earnings |
127 |
332 |
110 |
- |
16 |
585 |
||||||
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities |
(88) |
(35) |
(483) |
- |
283 |
(323) |
||||||
Change in actuarial methods and assumptions |
- |
- |
- |
- |
- |
- |
||||||
Restructuring charge |
- |
- |
- |
- |
- |
- |
||||||
Reinsurance transactions, tax related items and other |
29 |
15 |
- |
- |
- |
44 |
||||||
Core earnings (post-tax) |
$ |
571 |
$ |
316 |
$ |
479 |
$ |
304 |
$ |
(196) |
$ |
1,474 |
Income tax on core earnings (see above) |
89 |
86 |
110 |
57 |
(49) |
293 |
||||||
Core earnings (pre-tax) |
$ |
660 |
$ |
402 |
$ |
589 |
$ |
361 |
$ |
(245) |
$ |
1,767 |
(1) These items are disclosed under OSFI's Source of Earnings Disclosure (Life Insurance Companies) guideline. |
Core earnings, CER basis
4Q20 |
||||||||||||
(Canadian $ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
|
|
|
Global WAM |
Corporate and Other |
|
||||||
Core earnings (post-tax) |
$ |
571 |
$ |
316 |
$ |
479 |
$ |
304 |
$ |
(196) |
$ |
1,474 |
CER adjustment(1) |
(24) |
- |
(16) |
(6) |
(1) |
(47) |
||||||
Core earnings, CER basis (post-tax) |
$ |
547 |
$ |
316 |
$ |
463 |
$ |
298 |
$ |
(197) |
$ |
1,427 |
Income tax on core earnings, CER basis(2) |
87 |
86 |
106 |
56 |
(49) |
286 |
||||||
Core earnings, CER basis (pre-tax) |
$ |
634 |
$ |
402 |
$ |
569 |
$ |
354 |
$ |
(246) |
$ |
1,713 |
(1) The impact of updating foreign exchange rates to that which was used in 4Q21. |
(2) Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 4Q21. |
Core earnings available to common shareholders
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
Quarterly |
Full Year |
||||||||||||
4Q21 |
3Q21 |
2Q21 |
1Q21 |
4Q20 |
2021 |
2020 |
||||||||
Core earnings (post tax) |
$ |
1,708 |
$ |
1,517 |
$ |
1,682 |
$ |
1,629 |
$ |
1,474 |
$ |
6,536 |
$ |
5,516 |
Less: Preferred share dividends |
(71) |
(37) |
(64) |
(43) |
(43) |
(215) |
(171) |
|||||||
Core earnings available to common shareholders |
1,637 |
1,480 |
1,618 |
1,586 |
1,431 |
6,321 |
5,345 |
|||||||
CER adjustment(1) |
- |
(3) |
29 |
(13) |
(47) |
13 |
(303) |
|||||||
Core earnings available to common shareholders, CER basis |
$ |
1,637 |
$ |
1,477 |
$ |
1,647 |
$ |
1,573 |
$ |
1,384 |
$ |
6,334 |
$ |
5,042 |
(1) The impact of updating foreign exchange rates to that which was used in 4Q21. |
Core ROE
($ millions and based on actual foreign exchange rates in effect in the applicable reporting period) |
Quarterly |
Full Year |
|||||||||||||
4Q21 |
3Q21 |
2Q21 |
1Q21 |
4Q20 |
2021 |
2020 |
|||||||||
Core earnings available to common shareholders (post-tax) |
$ |
1,637 |
$ |
1,480 |
$ |
1,618 |
$ |
1,586 |
$ |
1,431 |
$ |
6,321 |
$ |
5,345 |
|
Annualized core earnings available to common shareholders (post-tax) |
$ |
6,483 |
$ |
5,874 |
$ |
6,485 |
$ |
6,435 |
$ |
5,697 |
$ |
6,321 |
$ |
5,345 |
|
Average common shareholders' equity (see below) |
$ |
51,049 |
$ |
49,075 |
$ |
46,757 |
$ |
46,974 |
$ |
48,984 |
$ |
48,463 |
$ |
49,145 |
|
Core ROE |
12.7% |
12.0% |
13.9% |
13.7% |
11.6% |
13.0% |
10.9% |
||||||||
Average common shareholders' equity |
|||||||||||||||
Total shareholders' and other equity |
$ |
58,408 |
$ |
55,457 |
$ |
53,466 |
$ |
51,238 |
$ |
52,335 |
$ |
58,408 |
$ |
52,335 |
|
Less: Preferred shares and other equity |
(6,381) |
(5,387) |
(5,387) |
(5,804) |
(3,822) |
(6,381) |
(3,822) |
||||||||
Common shareholders' equity |
$ |
52,027 |
$ |
50,070 |
$ |
48,079 |
$ |
45,434 |
$ |
48,513 |
$ |
52,027 |
$ |
48,513 |
|
Average common shareholders' equity |
$ |
51,049 |
$ |
49,075 |
$ |
46,757 |
$ |
46,974 |
$ |
48,984 |
$ |
48,463 |
$ |
49,145 |
Core EPS
($ millions and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
Quarterly |
Full Year |
|||||||||||||
4Q21 |
3Q21 |
2Q21 |
1Q21 |
4Q20 |
2021 |
2020 |
|||||||||
Core EPS |
|||||||||||||||
Core earnings available to common shareholders (post-tax) |
$ |
1,637 |
$ |
1,480 |
$ |
1,618 |
$ |
1,586 |
$ |
1,431 |
$ |
6,321 |
$ |
5,345 |
|
Diluted weighted average common shares outstanding (millions) |
1,946 |
1,946 |
1,946 |
1,945 |
1,943 |
1,946 |
1,943 |
||||||||
Core earnings per share |
0.84 |
0.76 |
0.83 |
0.82 |
0.74 |
3.25 |
2.75 |
||||||||
Core EPS, CER basis |
|||||||||||||||
Core earnings available to common shareholders (post-tax), CER basis |
$ |
1,637 |
$ |
1,477 |
$ |
1,647 |
$ |
1,573 |
$ |
1,384 |
$ |
6,334 |
$ |
5,042 |
|
Diluted weighted average common shares outstanding (millions) |
1,946 |
1,946 |
1,946 |
1,945 |
1,943 |
1,946 |
1,943 |
||||||||
Core earnings per share, CER basis |
0.84 |
0.76 |
0.85 |
0.81 |
0.71 |
3.26 |
2.59 |
||||||||
Global WAM AUMA reconciliation
As at |
||||||||||
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
2021 |
|
2021 |
2021 |
2020 |
|||||
Total invested assets |
$ |
427,098 |
$ |
419,087 |
$ |
405,209 |
$ |
397,948 |
$ |
410,977 |
Less: Non Global WAM total invested assets |
422,640 |
414,754 |
400,998 |
393,623 |
406,217 |
|||||
Total Invested Assets – Global WAM |
4,458 |
4,333 |
4,211 |
4,325 |
4,760 |
|||||
Total segregated funds net assets |
$ |
399,788 |
$ |
387,799 |
$ |
383,845 |
$ |
371,682 |
$ |
367,436 |
Less: Non Global WAM total segregated funds net assets |
147,221 |
143,248 |
141,227 |
137,220 |
137,609 |
|||||
Total Invested Assets – Global WAM |
252,567 |
244,551 |
242,618 |
234,462 |
229,827 |
|||||
Global WAM total invested assets and net segregated funds assets |
$ |
257,025 |
$ |
248,884 |
$ |
246,829 |
$ |
238,787 |
$ |
234,587 |
Global WAM AUMA |
||||||||||
Total Invested Assets |
$ |
4,458 |
$ |
4,333 |
$ |
4,211 |
$ |
4,325 |
$ |
4,760 |
Segregated funds net assets |
||||||||||
Segregated funds net assets - Institutional |
4,470 |
4,400 |
4,229 |
4,157 |
1,886 |
|||||
Segregated funds net assets - Other |
248,097 |
240,151 |
238,389 |
230,305 |
227,941 |
|||||
Total |
252,567 |
244,551 |
242,618 |
234,462 |
229,827 |
|||||
Mutual funds |
290,863 |
277,421 |
265,110 |
249,137 |
238,068 |
|||||
Institutional asset management(1) |
106,407 |
103,732 |
99,983 |
96,989 |
107,387 |
|||||
Other funds |
14,001 |
12,562 |
12,232 |
11,611 |
10,880 |
|||||
Total Global WAM AUM |
668,296 |
642,599 |
624,154 |
596,524 |
590,922 |
|||||
Assets under administration |
187,631 |
181,013 |
174,376 |
167,558 |
162,688 |
|||||
Total Global WAM AUMA |
$ |
855,927 |
$ |
823,612 |
$ |
798,530 |
$ |
764,082 |
$ |
753,610 |
Total Global WAM AUMA |
$ |
855,927 |
$ |
823,612 |
$ |
798,530 |
$ |
764,082 |
$ |
753,610 |
CER adjustment(2) |
- |
(3,191) |
12,587 |
4,244 |
(5,003) |
|||||
Total Global WAM AUMA, CER basis |
$ |
855,927 |
$ |
820,421 |
$ |
811,117 |
$ |
768,326 |
$ |
748,607 |
(1) Institutional asset management excludes Institutional segregated funds net assets. |
(2) The impact of updating foreign exchange rates to that which was used in 4Q21. |
Expense efficiency ratio
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated) |
Quarterly |
Full Year |
||||||||||||
4Q21 |
3Q21 |
2Q21 |
1Q21 |
4Q20 |
2021 |
2020 |
||||||||
Expense Efficiency Ratio |
||||||||||||||
Core general expenses |
$ |
1,973 |
$ |
1,904 |
$ |
1,794 |
$ |
1,882 |
$ |
1,968 |
$ |
7,553 |
$ |
7,501 |
Core earnings (pre-tax) |
2,054 |
1,811 |
2,036 |
1,995 |
1,767 |
7,896 |
6,684 |
|||||||
Total - Core earnings (pre-tax) and Core general expenses |
$ |
4,027 |
$ |
3,715 |
$ |
3,830 |
$ |
3,877 |
$ |
3,735 |
$ |
15,449 |
$ |
14,185 |
Expense Efficiency Ratio |
49.0% |
51.3% |
46.8% |
48.5% |
52.7% |
48.9% |
52.9% |
|||||||
Core general expenses |
||||||||||||||
General expenses - Financial Statements |
$ |
2,000 |
$ |
1,904 |
$ |
1,892 |
$ |
2,032 |
$ |
1,968 |
$ |
7,828 |
$ |
7,510 |
Less: General expenses included in items excluded from core earnings |
||||||||||||||
Restructuring charge |
- |
- |
- |
150 |
- |
150 |
- |
|||||||
Legal provisions and other expenses |
27 |
- |
98 |
- |
- |
125 |
9 |
|||||||
Total |
$ |
27 |
$ |
- |
$ |
98 |
$ |
150 |
$ |
- |
$ |
275 |
$ |
9 |
Core general expenses |
$ |
1,973 |
$ |
1,904 |
$ |
1,794 |
$ |
1,882 |
$ |
1,968 |
$ |
7,553 |
$ |
7,501 |
Core general expenses |
$ |
1,973 |
$ |
1,904 |
$ |
1,794 |
$ |
1,882 |
$ |
1,968 |
$ |
7,553 |
$ |
7,501 |
CER adjustment |
- |
(3) |
24 |
(18) |
(54) |
3 |
(312) |
|||||||
Core general expenses, CER basis |
$ |
1,973 |
$ |
1,901 |
$ |
1,818 |
$ |
1,864 |
$ |
1,914 |
$ |
7,556 |
$ |
7,189 |
CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the
The forward-looking statements in this document include, but are not limited to, statements with respect to possible share buybacks under our NCIB, the impact related to the reinsurance of our legacy
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements.
Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as available-for-sale; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public infrastructure systems; environmental concerns; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in our 2021 Management's Discussion and Analysis under "Risk Management and Risk Factors" and "Critical Actuarial and Accounting Policies" and in the "Risk Management" note to the Consolidated Financial Statements for the year ended
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/manulife-reports-strong-2021-results-with-record-net-income-of-7-1-billion-and-core-earnings-of-6-5-billion-with-double-digit-growth-in-ape-sales-and-new-business-value-global-wealth-and-asset-management-net-inflows-tripled-to-301479165.html
SOURCE
Sun Life declares dividends on Common and Preferred Shares payable in Q1 2022
American Financial Group, Inc. Announces Fourth Quarter and Full Year Results
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News